Partnerships
>
Latest News
Teva Agrees to Strategic Partnerships with Formycon AG, Klinge Biopharma, & Samsung Bioepis
January 14th 2025
New partnerships aim to expand Teva’s biosimilar portfolio and enhance access to high-cost biologics across key markets.
